Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study)

Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral

“…In addition, some authors have suggested also a lower rate of cerebrovascular events in their subclavian cohort . These positive results despite a higher perioperative risk are similar to those reported in the large ADVANCE study showing a constant trend that confers to the findings of this research a growing external validity.…”

“…These positive results despite a higher perioperative risk are similar to those reported in the large ADVANCE study [39] showing a constant trend that confers to the findings of this research a growing external validity.…”

Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site

“…Minor vascular complications (15%), mainly driven by local dissections (13%), were observed more frequently than described in previous transfemoral studies, which reported incidences of 5% to 10% [15,17,18]. It is unclear whether this finding can be related to either the routinely performed angiographic assessment for potential dissection or certain axillary artery characteristics predisposing to dissection.…”

“…Randomized trials and nonrandomized controlled trials of transfemoral TAVI describe incidences from 6% to 11% and 3% to 11%, respectively [3,[14][15][16][17]. Supported by Barbanti and colleagues [18], who described no significant difference in vascular outcome between highly (The Society of Thoracic Surgeons score more than 7) or less cardiovascular affected (The Society of Thoracic Surgeons score less than 7) transfemoral TAVI patients [18], we expect that the impact of patient characteristics on vascular outcome is relatively small. Based on our results, we hypothesize that the combination of axillary access by surgical cutdown [19], the proximity to the native valve with less bending of the delivery device, less shear stress along the aortic wall, and lower burden of atherosclerotic disease all contribute to favorable vascular outcome.…”

Comparison of late mortality after transcatheter aortic valve implantation versus surgical aortic valve replacement: Insights from a meta-analysis

“…The data on late outcomes after TAVI is starting to accumulate. Several studies have reported 3 to 7 years of outcome data after TAVI [7][8][9][10][11][12][13]. However, a number of studies that have reported comparative late outcomes between TAVI and surgical aortic valve replacement (SAVR) are relatively limited.…”